Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02224638 · ClinicalTrials.gov registry record · Phase 4
Wound Management for Sacral Pressure Ulcers With Necrotic Tissue
A Phase 4 study of Pressure Ulcers, sponsored by Medline Industries.
- Completed
- Registry status
- Phase 4
- Development phase
- 21
- Enrollment target
- 2
- Study locations
NCT02224638: Completed Phase 4 study of Pressure Ulcers, sponsored by Medline Industries.
NCT02224638 is a Phase 4 study of Pressure Ulcers that has completed, run by Medline Industries. The registered enrollment target is 21 participants, below the 230-participant average among 5 other Pressure Ulcers trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02224638, a Phase 4 study of Pressure Ulcers, has completed, sponsored by Medline Industries.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 21 participants
- Enrollment target
- 2
- Study locations
Study Summary
Evaluation of a wound care debridement product and a moisturizer on sacral pressure ulcer wounds
Primary Outcome
Percentage of wounds that were complete or partially healed with either treatment measured by change in wound size of sacral pressure ulcer
Conditions Studied
Interventions
- DEVICE TheraHoney HD
- DEVICE SkinTegrity
Study Locations (2)
Illinois
- Swedish Covenant Hospital - Chicago
- Harmony Residential Facility - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2014-12 |
| Est. Completion | 2015-08 |
| Phase | Phase 4 |
What the finished NCT02224638 record still lists
NCT02224638 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 230-participant average among 5 other Pressure Ulcers trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Pressure Ulcers appearing as the primary indexed condition, and to 2 interventions - of which TheraHoney HD is the first listed.
NCT02224638 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT02224638 about?
NCT02224638 is a clinical study titled "Wound Management for Sacral Pressure Ulcers With Necrotic Tissue". Evaluation of a wound care debridement product and a moisturizer on sacral pressure ulcer wounds
What is the current status of trial NCT02224638?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 21 participants. The study started on 2014-12. Estimated completion is 2015-08.
What conditions does trial NCT02224638 study?
This clinical trial studies the following conditions: Pressure Ulcers.
What interventions are being tested in trial NCT02224638?
The interventions under investigation include: TheraHoney HD (DEVICE), SkinTegrity (DEVICE).
Who is sponsoring clinical trial NCT02224638?
This trial is sponsored by Medline Industries, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02224638 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pressure Ulcers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Miro3D Wound Matrix for Healing Wounds and Ulcers in Outpatient Care
RECRUITING · NA
-
Wound Healing Endpoint and Recurrence
ACTIVE NOT RECRUITING · Phase 1
-
Pressure Ulcer Prevention: Turning for Ulcer Reduction
COMPLETED · Phase 3
-
Prospective PuraPly™ AM Case Series Study
COMPLETED
-
Development and Feasibility of an Internet Intervention for Adults With Spinal Cord Injury to Prevent Pressure Ulcers
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia